Toxicological assessment of Xanthigen？ nutraceutical extract combination: Mutagenicity, genotoxicity and oral toxicity

DOI: 10.1016/j.toxrep.2018.10.007

Keywords: LD50, oral lethal dose 50%, FX, fucoxanthin, PSO, pomegranate seed oil, BSE, brown seaweed extract, SFA, saturated fatty acids, MUFA, monounsaturated fatty acids, PUFA, polyunsaturated fatty acid, NOAEL, no observed adverse effect level, DMSO, dimethyl sulfoxide, SPF, specific pathogenic free, RCC, relative cell count, MMC, mitomycin, CPA, cytophosphadine, S9, metabolic activation system consisting of liver-derived cell extract, PCE, polychromatic erythrocytes, NCE, normochromatic erythrocytes, MNPCEs, micronucleated polychromatic erythrocytes, KFDA, Korean Food and Drug Administration Xanthigen, Functional foods, Genotoxicity, Nutraceutical, Oral toxicity

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text